Business Development Lead Andrew Turner Appointed
20th November 2017
The appointment of Andrew Turner as Business Development lead has brought new life to the introduction of Peezy Midstream technology to a number of leading NHS Trusts open to “getting it right first time” and reducing costs by making patients better, faster.
Eight Trusts have formed a collaboration of Microbiology, Nursing Directorates, Antimicrobial Resistance leads and others to oversee evaluations. This is the first time we have had access to cross-departmental evaluation, breaking down the decision-making silos that still dominate change within the NHS. Andrew has spent 25 years working across microbiology, medical devices and system change within the NHS and private health sectors in the UK and overseas.